Del Rosso JQ, Tanghetti E, Webster G, Stein Gold L, Thiboutot D, Gallo RL. Update on the Management of Rosacea from the American Acne & Rosacea Society (AARS). J Clin Aesthet Dermatol 2019;12(6):17-24. https://www.ncbi.nlm.nih.gov/pubmed/31360284
Hampton PJ, Berth-Jones J, Duarte Williamson CE, Hay R, Leslie TA, Porter I, et al. British Association of Dermatologists guidelines for the management of people with rosacea 2021*. British Journal of Dermatology 2021;185(4):725-35. https://onlinelibrary.wiley.com/doi/abs/10.1111/bjd.20485
Siddiqui K, Gold LS, Gill J. The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis. Springerplus 2016;5(1):1-19. https://www.ncbi.nlm.nih.gov/pubmed/27504249
Taieb A, Khemis A, Ruzicka T, Baranska-Rybak W, Berth-Jones J, Schauber J, et al. Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36-week extension of the ATTRACT randomized study. J Eur Acad Dermatol Venereol 2016;30(5):829-36. https://www.ncbi.nlm.nih.gov/pubmed/26691278
van Zuuren EJ, Fedorowicz Z, Carter B, van der Linden MM, Charland L. Interventions for rosacea. Cochrane Database Syst Rev 2015;4:CD003262. https://www.ncbi.nlm.nih.gov/pubmed/25919144
van Zuuren EJ, Fedorowicz Z, Tan J, van der Linden MMD, Arents BWM, Carter B, et al. Interventions for rosacea based on the phenotype approach: an updated systematic review including GRADE assessments. Br J Dermatol 2019;181(1):65-79. https://www.ncbi.nlm.nih.gov/pubmed/30585305
Weiss E, Katta R. Diet and rosacea: the role of dietary change in the management of rosacea. Dermatol Pract Concept 2017;7(4):31-7. https://www.ncbi.nlm.nih.gov/pubmed/29214107
